143 related articles for article (PubMed ID: 33741961)
1. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation.
Coassolo S; Davidson G; Negroni L; Gambi G; Daujat S; Romier C; Davidson I
Nat Commun; 2021 Mar; 12(1):1718. PubMed ID: 33741961
[TBL] [Abstract][Full Text] [Related]
2. The role of PKM2 in cancer progression and its structural and biological basis.
Wu B; Liang Z; Lan H; Teng X; Wang C
J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.
Nandi S; Dey M
J Biol Chem; 2020 Apr; 295(16):5390-5403. PubMed ID: 32144209
[TBL] [Abstract][Full Text] [Related]
4. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect.
Upadhyay S; Khan S; Hassan MI
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189089. PubMed ID: 38458358
[TBL] [Abstract][Full Text] [Related]
5. Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial Cancer Cells.
Tian S; Ren L; Liu C; Wang Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474453
[TBL] [Abstract][Full Text] [Related]
6. A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer.
Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE
Clin Cancer Res; 2022 Apr; 28(7):1446-1459. PubMed ID: 35078861
[TBL] [Abstract][Full Text] [Related]
7. Citrullination: new tricks for an old mod.
Christophorou MA; Sharma P; Zhang X
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220235. PubMed ID: 37778381
[No Abstract] [Full Text] [Related]
8. Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveal the effects of multiple oxidation on cellular oxidative stress response.
Irokawa H; Numasaki S; Kato S; Iwai K; Inose-Maruyama A; Ohdate T; Hwang GW; Toyama T; Watanabe T; Kuge S
Biochem J; 2021 Apr; 478(7):1453-1470. PubMed ID: 33749780
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.
Shangguan X; He J; Ma Z; Zhang W; Ji Y; Shen K; Yue Z; Li W; Xin Z; Zheng Q; Cao Y; Pan J; Dong B; Cheng J; Wang Q; Xue W
Nat Commun; 2021 Mar; 12(1):1812. PubMed ID: 33753739
[TBL] [Abstract][Full Text] [Related]
10. PKM2 Aggravates Cerebral Ischemia Reperfusion-Induced Neuroinflammation via TLR4/MyD88/TRAF6 Signaling Pathway.
Zhang B; Shen J; Zhong Z; Zhang L
Neuroimmunomodulation; 2021; 28(1):29-37. PubMed ID: 33744886
[TBL] [Abstract][Full Text] [Related]
11. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2.
Wang X; Wang J; Tsui YM; Shi C; Wang Y; Zhang X; Yan Q; Chen M; Jiang C; Yuan YF; Wong CM; Liu M; Feng ZY; Chen H; Ng IOL; Jiang L; Guan XY
Nat Commun; 2021 Mar; 12(1):1518. PubMed ID: 33750796
[TBL] [Abstract][Full Text] [Related]
12. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Alicea-Torres K; Sanseviero E; Gui J; Chen J; Veglia F; Yu Q; Donthireddy L; Kossenkov A; Lin C; Fu S; Mulligan C; Nam B; Masters G; Denstman F; Bennett J; Hockstein N; Rynda-Apple A; Nefedova Y; Fuchs SY; Gabrilovich DI
Nat Commun; 2021 Mar; 12(1):1717. PubMed ID: 33741967
[TBL] [Abstract][Full Text] [Related]
13. Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.
Xia Y; Liu Y; Yang C; Simeone DM; Sun TT; DeGraff DJ; Tang MS; Zhang Y; Wu XR
Nat Commun; 2021 Apr; 12(1):2047. PubMed ID: 33824349
[TBL] [Abstract][Full Text] [Related]
14. A novel proteomics approach to epigenetic profiling of circulating nucleosomes.
Van den Ackerveken P; Lobbens A; Turatsinze JV; Solis-Mezarino V; Völker-Albert M; Imhof A; Herzog M
Sci Rep; 2021 Mar; 11(1):7256. PubMed ID: 33790358
[TBL] [Abstract][Full Text] [Related]
15. The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardaś I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczyński A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P
Nat Commun; 2021 Mar; 12(1):1920. PubMed ID: 33772001
[TBL] [Abstract][Full Text] [Related]
16. PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer.
Xue T; Liu X; Zhang M; E Q; Liu S; Zou M; Li Y; Ma Z; Han Y; Thompson P; Zhang X
Adv Sci (Weinh); 2021 Mar; 8(6):2002831. PubMed ID: 33747724
[TBL] [Abstract][Full Text] [Related]
17. PAX8 and MECOM are interaction partners driving ovarian cancer.
Bleu M; Mermet-Meillon F; Apfel V; Barys L; Holzer L; Bachmann Salvy M; Lopes R; Amorim Monteiro Barbosa I; Delmas C; Hinniger A; Chau S; Kaufmann M; Haenni S; Berneiser K; Wahle M; Moravec I; Vissières A; Poetsch T; Ahrné E; Carte N; Voshol J; Bechter E; Hamon J; Meyerhofer M; Erdmann D; Fischer M; Stachyra T; Freuler F; Gutmann S; Fernández C; Schmelzle T; Naumann U; Roma G; Lawrenson K; Nieto-Oberhuber C; Cobos-Correa A; Ferretti S; Schübeler D; Galli GG
Nat Commun; 2021 Apr; 12(1):2442. PubMed ID: 33903593
[TBL] [Abstract][Full Text] [Related]
18. Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS.
Jourdain AA; Begg BE; Mick E; Shah H; Calvo SE; Skinner OS; Sharma R; Blue SM; Yeo GW; Burge CB; Mootha VK
Mol Cell; 2021 May; 81(9):1905-1919.e12. PubMed ID: 33852893
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.
Liu X; Hartman CL; Li L; Albert CJ; Si F; Gao A; Huang L; Zhao Y; Lin W; Hsueh EC; Shen L; Shao Q; Hoft DF; Ford DA; Peng G
Sci Transl Med; 2021 Mar; 13(587):. PubMed ID: 33790024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
